| Zugriffe | |
|---|---|
| Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 185 |
| Juni 2025 | Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | |
|---|---|---|---|---|---|---|---|
| Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis | 2 | 4 | 3 | 10 | 38 | 13 | 2 |
| Zugriffe | |
|---|---|
| 2020_Burmester_etal.pdf | 82 |
